Cristália's Business Units are as follows.
Hospital
Exclusively dedicated to products used in hospitals; This Business Unit serves 95% of the Brazilian hospitals. The main serviced areas include: anesthesiology, algology, intensive care and oncology, and as our last launch, antibiotic therapy.
Biologic
Dedicated essentially to products which increase the survival rate and the quality of life of immunosuppressive patients and chronic patients. Our line of products are under Biotechnological, antiretroviral and blood drugs, which act in the immunology, infectious diseases, nephrology, oncology, and rheumatology areas, among others.
Pharma
Exclusively dedicated to products for the RX pharmaceutical segment, this Business Units is responsible for drugs in the following areas: algology, primary care practice, dermatology, geriatrics, gynecology, neurology, oncology, orthopedics, psychiatry, rheumatology and urology.
Generics
Being sensitive to our National need for increasing population’s access to drugs, Cristália entered in the so called “generic market”, in 2001. Nowadays, it produces drugs for: cardiology, ophthalmology, lung diseases, dermatology, gynecology, among others.
Corporis
Launched in 2003, with its main focus on offering products that provides the possibility for every person to have a harmonious relationship with their bodies, either from the medical, cosmetic, aesthetic, physiotherapeutic or feeding point of views. Our first product is a very demanding one in the national market: Prosigne (Botulinum Toxin Type A).
|